组织芯片，组织微阵列

MBC721	多器官肿瘤组织组合芯片，附病理分级、TNM、临床分期，72例/72点
点数	72	例数	72
行数	8	列数	9
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Ski

-Skin

Sof

-Soft Tissue

Per

-Peripheral nerve

Mus

-Muscle

Mes

-Mesothelium

Tes

-Testis

Pro

-Prostate

Cer

-Cervix

Ute

-Uterus

Ova

-Ovary

Bre

-Breast

Spl

-Spleen

Lym

-Lymph nodes

Thy

-Thymus

Adr

-Adrenal gland

Thy

-Thyroid

Bla

-Bladder

Kid

-Kidney

App

-Appendix

Pan

-Pancreas

Gal

-Gallbladder

Liv

-Liver

Col

-Colon

Sma

-Small intestine

Sto

-Stomach

Eso

-Esophagus

Bon

-Bone

Bon

-Bone or extramedullary

Lun

-Lung

Sal

-Salivary gland

Ton

-Tongue

Hea

-Head and neck

Bra

-Brain

Malignant (*)

Malignant (I)

Malignant (IA)

Malignant (IB)

Malignant (II)

Malignant (IIA)

Malignant (IIB)

Malignant (III)

Malignant (IIIA)

Malignant (IIIB)

Malignant (IV)

TISSUE ARRAYS MBC721

	1	2	3	4	5	6	7	8	9
A	BRA	BRA	HEA	TON	SAL	SAL	LUN	LUN	LUN
B	LUN	BON	BON	ESO	ESO	STO	STO	SMA	SMA
C	SMA	COL	COL	COL	LIV	LIV	GAL	GAL	PAN
D	PAN	APP	APP	KID	KID	BLA	BLA	THY	THY
E	ADR	ADR	THY	THY	LYM	LYM	LYM	LYM	LYM
F	SPL	SPL	BRE	BRE	OVA	OVA	UTE	UTE	UTE
G	CER	CER	PRO	PRO	TES	TES	MES	MES	MUS
H	MUS	MUS	MUS	PER	PER	SOF	SOF	SKI	SKI

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	Tumor Size	isBackUp
A1	1	51	F	Brain	Oligodendroglioma	*	*	*	Malignant	*	N
A2	2	42	F	Brain	Ependymoma	*	*	*	Malignant	*	N
A3	3	41	M	Head and neck	Adenocarcinoma	*	T2N0M0	II	Malignant	944	N
A4	4	53	M	Tongue	Squamous cell carcinoma	*	T3N0M0	III	Malignant	5.5	N
A5	5	24	F	Salivary gland	Pleomorphic adenoma	*	*	*	Malignant	*	N
A6	6	49	M	Salivary gland	Warthin's tumor with necrosis	*	*	*	Malignant	*	N
A7	7	59	M	Lung	Adenocarcinoma	*	T2N0M0	IB	Malignant	52.52	N
A8	8	56	M	Lung	Squamous cell carcinoma	*	T3N2M0	IIIB	Malignant	765	N
A9	9	42	F	Lung	Small cell carcinoma	*	T4N1M0	IIIA	Malignant	*	N
B1	10	49	M	Lung	Atypical carcinoid	*	T4N2M0	IIIB	Malignant	*	N
B2	11	31	M	Bone or extramedullary	Multiple myeloma or plasmacytoma	*	*	*	Malignant	4.5	N
B3	12	19	M	Bone	Osteosarcoma	*	T2N0M0 G3	IIB	Malignant	*	N
B4	13	67	M	Esophagus	Adenocarcinoma	*	*	*	Malignant	*	N
B5	14	65	F	Esophagus	Squamous cell carcinoma	*	*	*	Malignant	42.51.5	N
B6	15	48	M	Stomach	Adenocarcinoma	*	T3N2M0	III	Malignant	5.55.00.5	N
B7	16	60	F	Stomach	Gastrointestinal stromal tumor (GIST)	*	*	*	Malignant	*	N
B8	17	56	F	Small intestine	Adenocarcinoma	*	T3N2M0	IIIB	Malignant	8.0	N
B9	18	38	M	Small intestine	Gastrointestinal stromal tumor (GIST)	*	*	*	Malignant	1075	N
C1	19	54	F	Small intestine	Neuroendocrine carcinoma	*	T3N2M0	IIIB	Malignant	7.0	N
C2	20	52	M	Colon	Adenocarcinoma	*	T3N2M0	IIIB	Malignant	320.5	N
C3	21	73	F	Colon	Squamous cell carcinoma	*	T3N2aM0	IIIB	Malignant	330.5cm	N
C4	22	46	M	Colon	Neuroendocrine carcinoma	*	T3N1M0	IIIB	Malignant	7.0	N
C5	23	62	M	Liver	Cholangiocarcinoma	*	T2aN0M0	II	Malignant	6.0	N
C6	24	58	M	Liver	Hepatocellular carcinoma	*	T2N0M0	II	Malignant	776	N
C7	25	59	M	Gallbladder	Adenocarcinoma (grade:2--3)	*	T2N1M0	IIIB	Malignant	*	N
C8	26	56	F	Gallbladder	Adenocarcinoma (grade:3)	*	T3N1M0	IIIB	Malignant	*	N
C9	27	58	M	Pancreas	Islet cell tumor	*	*	*	Malignant	*	N
D1	28	39	F	Pancreas	Ductal adenocarcinoma	*	T3N0M0	IIA	Malignant	431	N
D2	29	46	F	Appendix	Carcinoid	*	T2N0M1	IV	Malignant	*	N
D3	30	59	M	Appendix	Adenocarcinoma	*	T2N1M0	IIIA	Malignant	*	N
D4	31	54	F	Kidney	Papillary renal adenoma	*	*	*	Malignant	*	N
D5	32	71	F	Kidney	Renal cell carcinoma	*	T2N0M0	II	Malignant	4.0	N
D6	33	58	M	Bladder	Squamous cell carcinoma	*	T3N0M0	III	Malignant	332	N
D7	34	65	F	Bladder	Urothelial cell carcinoma	*	T3N0M0	III	Malignant	4.54.02	N
D8	35	45	M	Thyroid	Follicular thyroid cancer	*	T2N0M0	I	Malignant	*	N
D9	36	51	F	Thyroid	Papillary thyroid cancer	*	T3N1M0	I	Malignant	3.32.82.2	N
E1	37	17	F	Adrenal gland	Adenoma	*	*	*	Malignant	18106.5	N
E2	38	50	M	Adrenal gland	Pheochromocytoma	*	*	*	Malignant	655	N
E3	39	35	M	Thymus	Type B3 thymoma	*	*	*	Malignant	*	N
E4	40	48	M	Thymus	Thymic carcinoma	*	*	*	Malignant	866	N
E5	41	40	F	Lymph nodes	Islet cell tumor	*	*	*	Malignant	742.5	N
E6	42	17	M	Lymph nodes	Hodgkin's Lymphoma	*	*	*	Malignant	*	N
E7	43	44	M	Lymph nodes	Mantle cell lymphoma	*	*	*	Malignant	4*6	N
E8	44	59	M	Lymph nodes	Follicular lymphoma	*	*	*	Malignant	*	N
E9	45	30	M	Lymph nodes	T cell lymphoma	*	*	*	Malignant	*	N
F1	46	60	M	Spleen	Diffuse large B cell lymphoma	*	*	*	Malignant	*	N
F2	47	35	M	Spleen	Angiosarcoma	*	*	*	Malignant	*	N
F3	48	72	F	Breast	Invasive ductal carcinoma	*	*	*	Malignant	*	N
F4	49	41	F	Breast	Invasive lobular carcinoma	*	*	*	Malignant	*	N
F5	50	84	F	Ovary	Granular cell tumor	*	T1aN0M0	IA	Malignant	1060.8	N
F6	51	45	F	Ovary	Serous carcinoma	*	T1aN0M0	IA	Malignant	*	N
F7	52	63	F	Uterus	Clear cell carcinoma with necrosis	*	T3bN1M0	IIIB	Malignant	653	N
F8	53	53	F	Uterus	Endometrioid adenocarcinoma	*	T1bN0M0	IB	Malignant	5.04.51.0	N
F9	54	48	F	Uterus	Uterine leiomyosarcoma	*	T2N1M0	IIIB	Malignant	997	N
G1	55	41	F	Cervix	Adenocarcinoma	*	T1aN0M0	IA	Malignant	543	N
G2	56	76	F	Cervix	Squamous cell carcinoma	*	T2N0M0	II	Malignant	432.5	N
G3	57	73	M	Prostate	Adenocarcinoma (Gleason grade:4, Gleason score:4+4)	*	T2aN0M0	I	Malignant	43.53	N
G4	58	69	M	Prostate	Adenocarcinoma (Gleason grade:1, Gleason score:2+1)	*	T3N0M0	III	Malignant	432	N
G5	59	21	M	Testis	Embryonal carcinoma	*	T1N0M0	I	Malignant	*	N
G6	60	50	M	Testis	Seminoma	*	T1N0M0	I	Malignant	4.0	N
G7	61	38	F	Mesothelium	Mesothelioma	*	*	*	Malignant	14102	N
G8	62	F	34	Mesothelium	Pleural solitary fibrous tumor	*	*	*	Malignant	*	N
G9	63	20	F	Muscle	Alveolar rhabdomyosarcoma	*	T2N0M0 G4	IIIB	Malignant	855	N
H1	64	55	M	Muscle	Myxoma	*	*	*	Malignant	*	N
H2	65	40	F	Muscle	Myxoliposarcoma	*	T2aN0M0 G2	IIB	Malignant	5.0	N
H3	66	43	F	Muscle	Myxofibrosarcoma	*	T1bN0M0	IIA	Malignant	5.0	N
H4	67	55	F	Peripheral nerve	Neurofibrosarcoma	*	*	*	Malignant	*	N
H5	68	61	F	Peripheral nerve	Schwannoma	*	*	*	Malignant	*	N
H6	69	76	M	Soft Tissue	Angiosarcoma	*	*	*	Malignant	*	N
H7	70	42	M	Soft Tissue	Liposarcoma	*	T1bN0M0	IIA	Malignant	4.0	N
H8	71	55	M	Skin	Basal cell carcinoma	*	T2N0M0	II	Malignant	*	N
H9	72	68	M	Skin	Invasive melanoma	*	*	*	Malignant	*	N
Tissue Marker